eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
PresentationCancer
miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer
- Susanna Stinson1,*,
- Mark R. Lackner2,*,
- Alex T. Adai3,*,
- Nancy Yu1,
- Hyo-Jin Kim1,
- Carol O’Brien2,
- Jill Spoerke2,
- Suchit Jhunjhunwala4,
- Zachary Boyd2,
- Thomas Januario1,
- Robert J. Newman5,
- Peng Yue4,
- Richard Bourgon4,
- Zora Modrusan5,
- Howard M. Stern6,
- Søren Warming5,
- Frederic J. de Sauvage5,
- Lukas Amler2,
- Ru-Fang Yeh7, and
- David Dornan1,†
- 1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
- 2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
- 3Center for Bioinformatics and Molecular Biostatistics, University of California San Francisco, San Francisco, CA, USA.
- 4Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA.
- 5Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
- 6Department of Pathology, Genentech, Inc., South San Francisco, CA, USA.
- 7Department of Biostatistics, Genentech, Inc., South San Francisco, CA, USA.
- ↵†Presenter and corresponding author. E-mail: dornan.david{at}gene.com
↵* These authors contributed equally to this work
See allHide authors and affiliations
Science Signaling 16 Aug 2011:
Vol. 4, Issue 186, pp. pt5
DOI: 10.1126/scisignal.2002258
Vol. 4, Issue 186, pp. pt5
DOI: 10.1126/scisignal.2002258
Susanna Stinson
1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
Mark R. Lackner
2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
Alex T. Adai
3Center for Bioinformatics and Molecular Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Nancy Yu
1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
Hyo-Jin Kim
1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
Carol O’Brien
2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
Jill Spoerke
2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
Suchit Jhunjhunwala
4Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA.
Zachary Boyd
2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
Thomas Januario
1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
Robert J. Newman
5Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
Peng Yue
4Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA.
Richard Bourgon
4Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA.
Zora Modrusan
5Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
Howard M. Stern
6Department of Pathology, Genentech, Inc., South San Francisco, CA, USA.
Søren Warming
5Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
Frederic J. de Sauvage
5Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
Lukas Amler
2Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, CA, USA.
Ru-Fang Yeh
7Department of Biostatistics, Genentech, Inc., South San Francisco, CA, USA.
David Dornan
1Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, CA, USA.
Submit a Response to This Article
No eLetters have been published for this article.